Header cover image

Italian (Borsa Italiana) Healthcare Sector Analysis

UpdatedJan 30, 2023
DataAggregated Company Financials
  • 7D-0.8%
  • 3M2.2%
  • 1Y-17.2%
  • YTD-0.4%

Over the last 7 days, the Healthcare industry has remained flat, although notably Philogen gained 4.9%. Unfortunately though, the industry is down 17% over the past 12 months. Looking forward, earnings are forecast to grow by 12% annually.

Sector Valuation and Performance

Has the Italian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 30 Jan 2023€23.7b€7.4b€886.1m23.3x26.8x3.2x
Wed, 28 Dec 2022€23.4b€7.4b€886.1m22.1x26.5x3.2x
Fri, 25 Nov 2022€24.3b€7.4b€886.1m22.8x27.5x3.3x
Sun, 23 Oct 2022€22.6b€7.3b€908.8m18.8x24.8x3.1x
Tue, 20 Sep 2022€23.0b€7.2b€897.0m21.2x25.7x3.2x
Thu, 18 Aug 2022€25.2b€7.2b€887.4m23.8x28.4x3.5x
Sat, 16 Jul 2022€25.4b€6.9b€957.4m22.3x26.6x3.7x
Mon, 13 Jun 2022€23.1b€6.9b€957.4m19.7x24.1x3.4x
Wed, 11 May 2022€25.7b€6.9b€960.7m21.5x26.8x3.7x
Fri, 08 Apr 2022€30.8b€6.7b€949.7m24.2x32.5x4.6x
Sun, 06 Mar 2022€28.3b€6.8b€1.0b19.9x27.4x4.1x
Tue, 01 Feb 2022€31.7b€6.8b€1.0b22.2x30.9x4.6x
Thu, 30 Dec 2021€37.3b€6.8b€1.0b24.7x36.4x5.5x
Sat, 27 Nov 2021€36.9b€6.8b€1.0b23.5x36x5.4x
Mon, 25 Oct 2021€37.1b€6.6b€1.0b27.6x36.6x5.6x
Wed, 22 Sep 2021€37.9b€6.6b€1.0b27.1x37.3x5.7x
Fri, 20 Aug 2021€38.3b€6.4b€1.0b31.2x37.6x5.9x
Fri, 04 Jun 2021€31.9b€6.1b€925.0m26.1x34.5x5.3x
Mon, 08 Mar 2021€30.1b€5.8b€866.3m25.7x34.7x5.1x
Thu, 10 Dec 2020€30.7b€5.7b€815.4m34.1x37.7x5.4x
Wed, 02 Sep 2020€27.8b€5.5b€754.5m33.2x36.9x5x
Sat, 06 Jun 2020€26.4b€5.5b€736.0m27x35.8x4.8x
Tue, 10 Mar 2020€21.3b€5.5b€738.1m26.1x28.9x3.9x
Price to Earnings Ratio


Total Market Cap: €21.9bTotal Earnings: €738.1mTotal Revenue: €5.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Italian Healthcare Sector Price to Earnings3Y Average 32.2x202120222023
Current Industry PE
  • Investors are pessimistic on the Italian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 26.8x which is lower than its 3-year average PE of 32.2x.
  • The 3-year average PS ratio of 4.6x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 6.3% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Italian Healthcare sector?

IT Market1.13%
Life Sciences0.24%
Healthcare Services0.21%
Medical Equipment-0.67%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 30.5x.
    • Analysts are expecting annual earnings growth of 35.9%, which is higher than its past year's earnings decline of 4.0% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 109% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 7.4% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PHIL Philogen€14.984.9%
SRI Servizi Italia€1.399.1%
ABS Arterra Bioscience€2.599.3%
SVS Svas Biosana€9.752.5%
PRL Pierrel€0.182.1%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.